ReP USP - Resultado da busca

Filtros : "ANTIPARASITÁRIOS" "ACS Infectious Diseases" Limpar

Filtros

USP affiliated authors
- aguiar, anna caroline campos (~1)
- guido, rafael victório carvalho (~1)
- uliana, silvia reni bortolin (~1)
Date published
- 2021 (~2)
Subjects
- antiparasitários (2)
- antimaláricos (1)
- leishmania brasiliensis (1)
- malária (1)
- micrornas (1)

Indexado em
- indexado na web of science (~1)
Collaboration
Normalized affiliation
- universidade estadual de campinas (unicamp) (~1)
Non normalized affiliation
- departamento de parasitologia, instituto de ciências biomédicas, universidade de são paulo, são paulo, sp, brasil (~1)
- departamento de química orgánica, universidad de sevilla and centro de innovación en química avanzada, sevilla, spain (~1)
- global health and tropical medicine, instituto de higiene e medicina tropical, universidade de lisboa, lisboa, portugal (~1)
- takeda pharmaceutical company limited - tokyo - japan (~1)
- wellcome centre for integrative parasitology, institute of infection, immunity & inflammation, college of medical veterinary and life sciences, university of glasgow, glasgow, united kingdom (~1)
Countries of institutions of collaboration
- brasil (~1)
- espanha (~1)
- inglaterra (~1)
- japão (~1)
- portugal (~1)
Qualis 2013/2016 - Área
Qualis 2013/2016 - Nota
Qualis 2013/2016 - Área / Nota
Theses and Dissertations
Type
Área de concentração
Sigla do Departamento/Programa de Pós Graduação
Departamento/Programa de Pós Graduação
Keywords

Artigo de periodico
Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major (2021)
Espada, Caroline Ricce ; Wendt, Andreia Albuquerque ; Hornillos, Valentín ; Gluenz, Eva ; Coelho, Adriano Cappellazzo ; Uliana, Silvia Reni Bortolin
Source: ACS Infectious Diseases. Unidade: ICB
Subjects: PARASITOLOGIA, LEISHMANIA BRASILIENSIS, RESISTÊNCIA MICROBIANA ÀS DROGAS, ANTIPARASITÁRIOS, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, MICRORNAS, PROTEINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESPADA, Caroline Ricce et al. Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major. ACS Infectious Diseases, v. 7, n. 4, p. 849–858, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.0c00857. Acesso em: 18 nov. 2024.
APA
Espada, C. R., Wendt, A. A., Hornillos, V., Gluenz, E., Coelho, A. C., & Uliana, S. R. B. (2021). Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major. ACS Infectious Diseases, 7( 4), 849–858. doi:10.1021/acsinfecdis.0c00857
NLM
Espada CR, Wendt AA, Hornillos V, Gluenz E, Coelho AC, Uliana SRB. Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major [Internet]. ACS Infectious Diseases. 2021 ; 7( 4): 849–858.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00857
Vancouver
Espada CR, Wendt AA, Hornillos V, Gluenz E, Coelho AC, Uliana SRB. Ros3 (Lem3p/CDC50) gene dosage is implicated in miltefosine susceptibility in Leishmania (Viannia) braziliensis clinical isolates and in Leishmania (Leishmania) major [Internet]. ACS Infectious Diseases. 2021 ; 7( 4): 849–858.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00857
Artigo de periodico
Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors (2021)
Okaniwa, Masanori; Aguiar, Anna Caroline Campos; Guido, Rafael Victorio Carvalho
Source: ACS Infectious Diseases. Unidade: IFSC
Subjects: PLASMODIUM, MALÁRIA, ANTIMALÁRICOS, ANTIPARASITÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OKANIWA, Masanori e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, v. 7, n. 6, p. 1680-1689, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.1c00020. Acesso em: 18 nov. 2024.
APA
Okaniwa, M., Aguiar, A. C. C., & Guido, R. V. C. (2021). Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, 7( 6), 1680-1689. doi:10.1021/acsinfecdis.1c00020
NLM
Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020
Vancouver
Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024